- Home
- NEO vs ECPG Comparison
NEO vs ECPG Comparison
Compare NEO & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- ECPG
- Stock Information
- Founded
- NEO 2001
- ECPG 1998
- Country
- NEO United States
- ECPG United States
- Employees
- NEO N/A
- ECPG N/A
- Industry
- NEO Precision Instruments
- ECPG Finance Companies
- Sector
- NEO Health Care
- ECPG Finance
- Exchange
- NEO Nasdaq
- ECPG Nasdaq
- Market Cap
- NEO 963.9M
- ECPG 905.2M
- IPO Year
- NEO 1999
- ECPG 1999
- Fundamental
- Price
- NEO $5.10
- ECPG $36.97
- Analyst Decision
- NEO Buy
- ECPG Strong Buy
- Analyst Count
- NEO 8
- ECPG 3
- Target Price
- NEO $12.14
- ECPG $62.67
- AVG Volume (30 Days)
- NEO 2.3M
- ECPG 208.3K
- Earning Date
- NEO 07-29-2025
- ECPG 08-06-2025
- Dividend Yield
- NEO N/A
- ECPG N/A
- EPS Growth
- NEO N/A
- ECPG N/A
- EPS
- NEO N/A
- ECPG N/A
- Revenue
- NEO $689,189,000.00
- ECPG $1,380,750,000.00
- Revenue This Year
- NEO $13.83
- ECPG $21.70
- Revenue Next Year
- NEO $11.35
- ECPG $8.86
- P/E Ratio
- NEO N/A
- ECPG N/A
- Revenue Growth
- NEO 9.70
- ECPG 11.49
- 52 Week Low
- NEO $4.81
- ECPG $26.45
- 52 Week High
- NEO $19.12
- ECPG $51.77
- Technical
- Relative Strength Index (RSI)
- NEO 24.08
- ECPG 38.41
- Support Level
- NEO $4.81
- ECPG $37.57
- Resistance Level
- NEO $6.61
- ECPG $39.42
- Average True Range (ATR)
- NEO 0.37
- ECPG 1.16
- MACD
- NEO -0.15
- ECPG -0.26
- Stochastic Oscillator
- NEO 10.86
- ECPG 5.43
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.